NOMATEN - archive
This archive also has a search function.
Intetrnational Scientific Committee is currently reviewing the applications for the post of the Research Group Leader for novel radiopharmaceuticals for medical applications.
The results will be released soon.
The Graduate School of Physics and Chemistry was established in 2019.
Part of the NOMATEN team visited MARIA nuclear research reactor at the National Centre for Nuclear Research on August 4th.
CEA: A preclinical study shows that hydroxychloroquine has no antiviral effect on SARS-CoV-2 in vivo
A study on the effects of hydroxychloroquine in macaques infected with the SARS-CoV-2 virus, used alone or in combination with azithromycin, have been published on Nature, July 22th.
New researchers joined NOMATEN team on August. Amin Esfandiarpour PhD and Francisco Javier Dominguez Gutierrez PhD will support director Mikko Alava within his research group.
Can the lifetime of a material, material solution or product be assessed accurately and in a cost-efficient way while extending its ultimate lifetime?
We are looking for a professional who will tak the position of Research Group Leader for novel radiopharmaceuticals for medical applications.
DEADLINE: 15-09-2020
Ms. Renata Mikołajczak is a professor at the NCBJ, representative of the Director for Scientific Affairs and National and International Cooperation at the POLATOM Radioisotope Center.
Javier Francisco Dominguez Gutierrez from from Max Planck Institute for Plasma Physics gave a lecture on the topic Classification and quantification of materia
On 24 – 26 September 2019 the Nomaten Teaming Phase 2 project representatives attended the European Research and Innovation Days, the first annual policy event of the European Commission bringing together stakeholders to debate and shape the future research and innovation landscape.